PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 24863079

  • 1. Interleukin-6 blockade improves autonomic dysfunction in rheumatoid arthritis.
    Syngle A, Verma I, Krishan P.
    Acta Reumatol Port; 2015; 40(1):85-8. PubMed ID: 24863079
    [Abstract] [Full Text] [Related]

  • 2. Disease-modifying anti-rheumatic drugs improve autonomic neuropathy in arthritis: DIANA study.
    Syngle A, Verma I, Krishan P, Garg N, Syngle V.
    Clin Rheumatol; 2015 Jul; 34(7):1233-41. PubMed ID: 24928343
    [Abstract] [Full Text] [Related]

  • 3. Predictors of autonomic neuropathy in rheumatoid arthritis.
    Syngle V, Syngle A, Garg N, Krishan P, Verma I.
    Auton Neurosci; 2016 Dec; 201():54-59. PubMed ID: 27503343
    [Abstract] [Full Text] [Related]

  • 4. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjögren syndrome and other autoimmune diseases.
    Stojanovich L, Milovanovich B, de Luka SR, Popovich-Kuzmanovich D, Bisenich V, Djukanovich B, Randjelovich T, Krotin M.
    Lupus; 2007 Dec; 16(3):181-5. PubMed ID: 17432103
    [Abstract] [Full Text] [Related]

  • 5. Autonomic function and rheumatoid arthritis: a systematic review.
    Adlan AM, Lip GY, Paton JF, Kitas GD, Fisher JP.
    Semin Arthritis Rheum; 2014 Dec; 44(3):283-304. PubMed ID: 25151910
    [Abstract] [Full Text] [Related]

  • 6. Cardiac autonomic dysfunction in patients with systemic lupus, rheumatoid arthritis and sudden death risk.
    Milovanović B, Stojanović L, Milićevik N, Vasić K, Bjelaković B, Krotin M.
    Srp Arh Celok Lek; 2010 Dec; 138(1-2):26-32. PubMed ID: 20422909
    [Abstract] [Full Text] [Related]

  • 7. Brief report: inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis.
    Samson M, Audia S, Janikashvili N, Ciudad M, Trad M, Fraszczak J, Ornetti P, Maillefert JF, Miossec P, Bonnotte B.
    Arthritis Rheum; 2012 Aug; 64(8):2499-503. PubMed ID: 22488116
    [Abstract] [Full Text] [Related]

  • 8. [Functional assessment of the autonomic nervous system in rheumatoid arthritis].
    Soares JD, Ferreira M, Póvoa P, da Silva JA, Santos MJ, Carlos AG.
    Acta Med Port; 1993 Jun; 6(6):245-8. PubMed ID: 8368090
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular and pupillary autonomic nervous dysfunction in patients with rheumatoid arthritis - a cross-sectional and longitudinal study.
    Schwemmer S, Beer P, Schölmerich J, Fleck M, Straub RH.
    Clin Exp Rheumatol; 2006 Jun; 24(6):683-9. PubMed ID: 17207385
    [Abstract] [Full Text] [Related]

  • 10. Clinical pharmacology of tocilizumab for the treatment of patients with rheumatoid arthritis.
    Zhang X, Peck R.
    Expert Rev Clin Pharmacol; 2011 Sep; 4(5):539-58. PubMed ID: 22114882
    [Abstract] [Full Text] [Related]

  • 11. Prothrombotic biomarkers in patients with rheumatoid arthritis: the beneficial effect of IL-6 receptor blockade.
    Gualtierotti R, Ingegnoli F, Griffini S, Grovetti E, Meroni PL, Cugno M.
    Clin Exp Rheumatol; 2016 Sep; 34(3):451-8. PubMed ID: 27086948
    [Abstract] [Full Text] [Related]

  • 12. Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus.
    Aydemir M, Yazisiz V, Basarici I, Avci AB, Erbasan F, Belgi A, Terzioglu E.
    Lupus; 2010 Mar; 19(3):255-61. PubMed ID: 20015916
    [Abstract] [Full Text] [Related]

  • 13. Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis.
    Shimamoto K, Ito T, Ozaki Y, Amuro H, Tanaka A, Nishizawa T, Son Y, Inaba M, Nomura S.
    J Rheumatol; 2013 Jul; 40(7):1074-81. PubMed ID: 23637318
    [Abstract] [Full Text] [Related]

  • 14. Tocilizumab for treating rheumatoid arthritis: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacy.
    Song SN, Yoshizaki K.
    Expert Opin Drug Metab Toxicol; 2015 Feb; 11(2):307-16. PubMed ID: 25491492
    [Abstract] [Full Text] [Related]

  • 15. A case of peripheral neuropathy and skin ulcer in a patient with rheumatoid arthritis after a single infusion of tocilizumab.
    Sugiura F, Kojima T, Oguchi T, Urata S, Yuzawa Y, Sakakibara A, Hayashi H, Nishimoto N, Ishiguro N.
    Mod Rheumatol; 2009 Feb; 19(2):199-203. PubMed ID: 18987779
    [Abstract] [Full Text] [Related]

  • 16. [Interleukin-6 inhibition and cardiovascular disease in patients with rheumatoid arthritis].
    Popkova TV, Novikova DS, Nasonov EL.
    Ter Arkh; 2016 Feb; 88(5):93-101. PubMed ID: 27458623
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular parasympathetic nervous system dysfunction in female rheumatoid arthritis patients.
    Saraswathi PV, Neelambikai N, Mahesh A, Govindarajan K.
    Indian J Physiol Pharmacol; 2013 Feb; 57(1):23-30. PubMed ID: 24020095
    [Abstract] [Full Text] [Related]

  • 18. IL-6 blockade reverses the abnormal STAT activation of peripheral blood leukocytes from rheumatoid arthritis patients.
    Ortiz MA, Diaz-Torné C, Hernández MV, Reina D, de la Fuente D, Castellví I, Moya P, Ruiz JM, Corominas H, Zamora C, Cantó E, Sanmartí R, Juarez C, Vidal S.
    Clin Immunol; 2015 Jun; 158(2):174-82. PubMed ID: 25847223
    [Abstract] [Full Text] [Related]

  • 19. Remarkable efficacy of tocilizumab for treating rheumatoid arthritis in patients with high platelet counts.
    Matsuno H.
    Mod Rheumatol; 2015 Jan; 25(1):38-42. PubMed ID: 25529071
    [Abstract] [Full Text] [Related]

  • 20. Interrelated reduction of chemerin and plasminogen activator inhibitor-1 serum levels in rheumatoid arthritis after interleukin-6 receptor blockade.
    Makrilakis K, Fragiadaki K, Smith J, Sfikakis PP, Kitas GD.
    Clin Rheumatol; 2015 Mar; 34(3):419-27. PubMed ID: 24912961
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.